Citigroup Reiterates Buy on CME Gr, Maintains $210 Price Target
Portfolio Pulse from richadhand@benzinga.com
Citigroup analyst Christopher Allen has reiterated a 'Buy' rating on CME Group (NASDAQ:CME) and maintained a price target of $210.
July 06, 2023 | 12:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup has reiterated a 'Buy' rating on CME Group and maintained a price target of $210.
The reiteration of a 'Buy' rating by Citigroup indicates a positive outlook for CME Group. The maintained price target of $210 suggests that Citigroup believes the stock has potential for growth. This could lead to increased investor confidence and a potential rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100